Obesity & Diabetes Week is the first and most comprehensive newsletter to cover weight gain and Type 2 diabetes research for disease treatment and drug development.
Not only does Obesity & Diabetes Week bring you more reports, but more coverage of every aspect of obesity and diabetes research, from drug candidate identification through launch and beyond.
Published weekly, each issue of Obesity & Diabetes Week has an average of more than 150 articles that cover obesity and diabetes research from A-Z, including diet, nutrition and metabolism, obesity and diabetes epidemiology, pathology and therapies, comorbidities, such as heart disease and atherosclerosis, as well as genetic, genomic and proteomic studies.
But important obesity and diabetes research news is only half the picture. Obesity & Diabetes Week also provides key business intelligence regarding marketing, distribution, licensing, regulatory actions, personnel and funding for the pharmaceutical and biotech companies involved in obesity and diabetes research and drug manufacturing.
NewsRx editors collect coverage from more than 4,000 peer-reviewed journals, dozens of industry meetings, medical news wires, pharmaceutical and biotech company internet sites, purchased databases, and press releases.
Each article, usually no more than 500 words, is written to be an information-heavy, concise report of the important facts, together with full references and citations for original source material. You get a fast, user-friendly read that keeps you on top of all the important obesity and diabetes research-related developments for that week.
Obesity & Diabetes Week is available in print or online at www.NewsRx.com. Email versions can be delivered directly to your desktop. Site licenses are also available for corporate use.
Combination print and email subscriptions are available, and all subscriptions come with online access to Obesity & Diabetes Week's archives, which go back to January 2003. See a sample issue here
Obesity & Diabetes Week was the first and only newsletters dedicated solely to reporting on the obesity epidemic and its associated rise in Type 2 diabetes. We stake our 20-plus year history as a healthcare publisher that it remains the best.
But don't take our word for it. Sign up for our six-week, no-risk free trial and see for yourself. Receive six issues of Obesity & Diabetes Week, more than 500 articles, and see why it will become your indispensable tool for tracking obesity and diabetes research news and developments.
Subscribe now and we'll give you $300 off our regular subscription price. You get the power of the most comprehensive obesity and diabetes research coverage in the industry at a great discount.
Start today, and eliminate all those hours you normally spend scanning dozens of periodicals, websites, and other information sources. We've done it for you; Obesity & Diabetes Week has you covered.
|
2009
